Sequani Medical

Sequani Medical operates as a specialized contract research organization (CRO) providing essential preclinical toxicology and safety assessment services. Founded in 2015 and based in Ledbury, UK, it serves clients in drug development, crop protection, and chemical safety under regulations like REACH. The company leverages scientific expertise and flexible project management to help customers navigate complex regulatory pathways and de-risk their development programs. Its business model is entirely service-based, generating revenue through contracted research studies.

Integrated preclinical safety testing services encompassing toxicology, pharmacokinetics, bioanalysis, and pathology, with specialized capabilities in microsampling and regulatory compliance.

Sequani competes in the fragmented preclinical CRO market against large global players (e.g., Charles River, Labcorp, ICON) and numerous regional/specialized CROs. Differentiation is achieved through focused toxicology expertise, flexible service models, and a client-centric approach tailored to small and mid-sized developers.